LabAnalysis x KairosTech: entering the pharma market in Korea

LabAnalysis closes 2022 with a new strategic partnership with KairosTech, a company present in the Korean pharma market for technical support, consultancy, packaging and APIs.

The agreement, recently signed by Luigino Maggi - CEO of LabAnalysis - and An Byungjune - Representative Director di KairosTech -, envisages a solid synergy in the link between consultancy and analytical testing throughout the South Korean territory.

The advantages for the parties are twofold: LabAnalysis officially lands in the Asian market, in collaboration with an already consolidated partner - moreover, an official Agilent Technologies distributor - which will be able to rely on Italian technical expertise for specific analyses in the pharmaceutical sector.

CPHI Korea 2023 will therefore be the right opportunity to discover this new collaboration!

From left to right: Bona Chung (Sales & Marketing Manager - KairosTech), Daeryoung Park (CCO - KairosTech), Byungjune An (Sales & Marketing Director - KairosTech), Luigino Maggi (CEO - LabAnalysis), Simone Vignola (Pharma Sales Manager - LabAnalysis) 

For more information
Simone Vignola - Pharma Sales Manager - simone.vignola@labanalysis.it